AIM
AIM ImmunoTech Inc.
Key Financials
Operating Income
$-11664000
↑ 41.0%
EPS (Diluted)
$-8.62
↓ 2680.6%
Net Income
$-13958000
↑ 19.4%
Total Assets
$5.8M
↓ 32.8%
Revenue
$88000
↓ 48.2%
Total Liabilities
$15.6M
↑ 56.7%
Cash & Equivalents
$3.0M
↑ 75.5%
Shareholders' Equity
$-9783000.00
↓ 640.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AIM |
| Company Name | AIM ImmunoTech Inc. |
| CIK | 946644 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 352-448-7797 |